AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2012
Dec 6, 2012
35124_dirs_2012-12-06_85474c67-ba9a-48f1-9a02-37b25d470ffe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2012-12-05
Reporting Person: Martinez Alberto R Jr (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-05 | Celsion Corporation Common Stock | M | 34583 | $3.25 | Acquired | 156625 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-05 | Warrants to purchase Celsion Corporation Common Stock | $3.25 | X | 34583 | Disposed | 2016-07-13 | Celsion Corporation Common Stock (34583) | Direct |
Footnotes
F1: The Director purchased Celsion Corporation Common Stock through the exercise of warrants obtained in the Janaury 2011 Preferred Stock Offering. These warrants were fully exercisable with an exercise price of $3.25 per share. The Director has no immediate intent to sell these newly acquired shares.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23